rs6831659

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_173660.5(DOK7):​c.1134G>A​(p.Ala378Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.208 in 1,590,450 control chromosomes in the GnomAD database, including 38,311 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A378A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.18 ( 3380 hom., cov: 34)
Exomes 𝑓: 0.21 ( 34931 hom. )

Consequence

DOK7
NM_173660.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.09

Publications

20 publications found
Variant links:
Genes affected
DOK7 (HGNC:26594): (docking protein 7) The protein encoded by this gene is essential for neuromuscular synaptogenesis. The protein functions in aneural activation of muscle-specific receptor kinase, which is required for postsynaptic differentiation, and in the subsequent clustering of the acetylcholine receptor in myotubes. This protein can also induce autophosphorylation of muscle-specific receptor kinase. Mutations in this gene are a cause of familial limb-girdle myasthenia autosomal recessive, which is also known as congenital myasthenic syndrome type 1B. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
DOK7 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 10
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • fetal akinesia deformation sequence 3
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 4-3493120-G-A is Benign according to our data. Variant chr4-3493120-G-A is described in ClinVar as Benign. ClinVar VariationId is 128905.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.09 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.495 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DOK7NM_173660.5 linkc.1134G>A p.Ala378Ala synonymous_variant Exon 7 of 7 ENST00000340083.6 NP_775931.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DOK7ENST00000340083.6 linkc.1134G>A p.Ala378Ala synonymous_variant Exon 7 of 7 1 NM_173660.5 ENSP00000344432.5

Frequencies

GnomAD3 genomes
AF:
0.182
AC:
27667
AN:
152054
Hom.:
3385
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0539
Gnomad AMI
AF:
0.279
Gnomad AMR
AF:
0.146
Gnomad ASJ
AF:
0.199
Gnomad EAS
AF:
0.512
Gnomad SAS
AF:
0.223
Gnomad FIN
AF:
0.380
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.207
Gnomad OTH
AF:
0.186
GnomAD2 exomes
AF:
0.222
AC:
45117
AN:
203522
AF XY:
0.224
show subpopulations
Gnomad AFR exome
AF:
0.0533
Gnomad AMR exome
AF:
0.142
Gnomad ASJ exome
AF:
0.210
Gnomad EAS exome
AF:
0.490
Gnomad FIN exome
AF:
0.378
Gnomad NFE exome
AF:
0.204
Gnomad OTH exome
AF:
0.211
GnomAD4 exome
AF:
0.210
AC:
302498
AN:
1438278
Hom.:
34931
Cov.:
113
AF XY:
0.211
AC XY:
150616
AN XY:
714238
show subpopulations
African (AFR)
AF:
0.0469
AC:
1553
AN:
33108
American (AMR)
AF:
0.140
AC:
5887
AN:
42022
Ashkenazi Jewish (ASJ)
AF:
0.211
AC:
5436
AN:
25746
East Asian (EAS)
AF:
0.505
AC:
19382
AN:
38370
South Asian (SAS)
AF:
0.206
AC:
17290
AN:
83772
European-Finnish (FIN)
AF:
0.378
AC:
17590
AN:
46524
Middle Eastern (MID)
AF:
0.147
AC:
845
AN:
5744
European-Non Finnish (NFE)
AF:
0.201
AC:
222005
AN:
1103496
Other (OTH)
AF:
0.210
AC:
12510
AN:
59496
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
17651
35303
52954
70606
88257
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7744
15488
23232
30976
38720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.182
AC:
27665
AN:
152172
Hom.:
3380
Cov.:
34
AF XY:
0.189
AC XY:
14091
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0538
AC:
2236
AN:
41564
American (AMR)
AF:
0.146
AC:
2237
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.199
AC:
690
AN:
3470
East Asian (EAS)
AF:
0.511
AC:
2630
AN:
5146
South Asian (SAS)
AF:
0.223
AC:
1079
AN:
4828
European-Finnish (FIN)
AF:
0.380
AC:
4027
AN:
10584
Middle Eastern (MID)
AF:
0.187
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
0.207
AC:
14065
AN:
67960
Other (OTH)
AF:
0.186
AC:
392
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1106
2213
3319
4426
5532
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
306
612
918
1224
1530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.165
Hom.:
1080
Bravo
AF:
0.160
Asia WGS
AF:
0.363
AC:
1266
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 23, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 03, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 19, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Fetal akinesia deformation sequence 1;C1850792:Congenital myasthenic syndrome 10 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.27
DANN
Benign
0.77
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6831659; hg19: chr4-3494847; COSMIC: COSV60771666; COSMIC: COSV60771666; API